A lower expression of DDB2, as observed in some of the XPCoxa-inactive cells, can therefore at least partially explain why some colon cancer cells lack an effective GG-NER response to oxaliplatin-induced intrastrand crosslinks. The gene discussed is DDB2; the disease is colonic neoplasm.